Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin
Navid M. Farsijani, … , Paul M. O’Connor, Volker H. Haase
Navid M. Farsijani, … , Paul M. O’Connor, Volker H. Haase
Published February 29, 2016
Citation Information: J Clin Invest. 2016;126(4):1425-1437. https://doi.org/10.1172/JCI74997.
View: Text | PDF
Research Article Nephrology

Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin

  • Text
  • PDF
Abstract

The adult kidney plays a central role in erythropoiesis and is the main source of erythropoietin (EPO), an oxygen-sensitive glycoprotein that is essential for red blood cell production. Decreases of renal pO2 promote hypoxia-inducible factor 2–mediated (HIF-2–mediated) induction of EPO in peritubular interstitial fibroblast-like cells, which serve as the cellular site of EPO synthesis in the kidney. It is not clear whether HIF signaling in other renal cell types also contributes to the regulation of EPO production. Here, we used a genetic approach in mice to investigate the role of renal epithelial HIF in erythropoiesis. Specifically, we found that HIF activation in the proximal nephron via induced inactivation of the von Hippel–Lindau tumor suppressor, which targets the HIF-α subunit for proteasomal degradation, led to rapid development of hypoproliferative anemia that was associated with a reduction in the number of EPO-producing renal interstitial cells. Moreover, suppression of renal EPO production was associated with increased glucose uptake, enhanced glycolysis, reduced mitochondrial mass, diminished O2 consumption, and elevated renal tissue pO2. Our genetic analysis suggests that tubulointerstitial cellular crosstalk modulates renal EPO production under conditions of epithelial HIF activation in the kidney.

Authors

Navid M. Farsijani, Qingdu Liu, Hanako Kobayashi, Olena Davidoff, Feng Sha, Joachim Fandrey, T. Alp Ikizler, Paul M. O’Connor, Volker H. Haase

×

Figure 2

Renal epithelial Vhl inactivation results in anemia.

Options: View larger image (or click on image) Download as PowerPoint
Renal epithelial Vhl inactivation results in anemia.
Hematologic effects...
Hematologic effects of Pax8-rtTA–mediated inactivation of Vhl in the absence of hepatic EPO induction. (A) Genomic PCR analysis of DNA isolated from kidney, liver, and tail of P8;Vhlfl/fl Epofl/fl and Cre– control mice. (B) Hct, Hb, and rbc counts in P8;Vhlfl/fl Epofl/fl, P8;Epofl/fl, and control (n = 5 each). (C) Corresponding reticulocyte counts (Retic.) and RPI in P8;Vhlfl/fl Epofl/fl and control mice (n = 5 each). (D) Relative renal and hepatic Epo mRNA levels in P8;Vhlfl/fl Epofl/fl and control mice (top panel, n = 5 each) and P8;Epofl/fl (bottom panel; n = 6 kidney samples and n = 3 liver samples) in comparison with control mice (n = 8 kidney samples and n = 3 liver samples). (E) Schematic depicting cellular contributions to sEPO levels in P8;Epofl/fl single mutants (left panel) and P8;Vhlfl/fl Epofl/fl double mutants (right panel). Red x indicates Cre-mediated gene inactivation; black x indicates that the Epo gene is not transcribed in tubular epithelial cells. The tildes indicate that Epo is not detectable in hepatocytes under baseline conditions. EPO production in the liver is no longer increased in P8;Vhlfl/fl Epofl/fl double mutants (right panel). **P < 0.01; ***P < 0.001, 1-way ANOVA followed by Dunnett’s post hoc analysis (B); unpaired 2-tailed Student’s t test (C and D). Shown are mean values ± SEM. 2-lox, nonrecombined conditional Vhl or Epo allele; 1-lox, recombined allele. See Supplemental Figure 2 for additional information.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts